About Us
Biocodex at a glance
Since 1953, Biocodex teams have been passionately committed to a single mission: providing innovative healthcare solutions to women, men and children worldwide. Present in more than 100 countries, Biocodex’s employees are committed to serving millions of patients around the world. We apply our expertise to developing and marketing a wide range of products to meet patient needs, focusing on three pillars: Microbiota care, women’s health and orphan diseases.
Biocodex key figures
- An international pharmaceutical company serving patients in more than 100 countries
- € 634M in revenue 2024
- 3 key areas of expertise: microbiota care, women’s health and orphan diseases.
- Founded in 1953 to market Saccharomyces boulardii CNCM I-745®, the world’s first probiotic yeast strain for human medicine
- More than 1,800 employees of 38 nationalities
- 3 industrial facilities in France and Morocco
- 1 R&D center in France
- Subsidiaries in 17 countries
- Presence in more than 100 countries through our distributors
- An investor in 5 startups specialized in innovative health solutions
May 5th, 2025 figures
